Literature DB >> 9657093

Optimal timing of liver transplantation for primary biliary cirrhosis.

W R Kim1, R H Wiesner, T M Therneau, J J Poterucha, M K Porayko, R W Evans, G B Klintmalm, J S Crippin, R A Krom, E R Dickson.   

Abstract

In 1989, we reported on the efficacy of liver transplantation in primary biliary cirrhosis (PBC) by demonstrating that the actual patient survival following transplantation was significantly better than without transplantation as predicted by a mathematical survival model ("Mayo natural history model"). Our aim in this investigation was to determine an optimal time to perform liver transplantation in PBC. One hundred forty-three patients with PBC undergoing liver transplantation were followed prospectively. Disease severity was measured immediately before transplantation by a summary score ("risk score") used in the Mayo natural history model, namely age, bilirubin, albumin, prothrombin time, and the presence or absence of edema. Proportional hazards analyses were performed assessing patient survival following transplantation. The influence of disease severity immediately pretransplantation on resource utilization for liver transplantation was assessed. Compared with our report in 1989, liver transplantation was performed at an earlier stage of disease (e.g., median risk score: 7.5 vs. 8.3; P < .01). Following transplantation, patient survival probabilities at 1, 2, and 5 years were 93%, 90%, and 88%, respectively. In the proportional hazards analysis, the risk of death following transplantation remained low until reaching a risk score of 7.8. In contrast, risk scores greater than 7.8 were associated with a progressively increased mortality. Resource utilization measured by the days in the intensive care unit (ICU) and hospital and the requirement for intraoperative blood transfusions was significantly greater in recipients who had higher risk scores before transplantation. Our data suggest that an optimal timing for liver transplantation, as determined by patient survival and resource utilization, appears to be at a risk score around 7.8 in patients with PBC.

Entities:  

Mesh:

Year:  1998        PMID: 9657093     DOI: 10.1002/hep.510280106

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Primary Biliary Cirrhosis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

Review 2.  Management of primary biliary cirrhosis: from diagnosis to end-stage disease.

Authors:  K N Lazaridis; K D Lindor
Journal:  Curr Gastroenterol Rep       Date:  2000-04

3.  Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Florian Loehe; Rolf J Schauer
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

4.  Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Authors:  Takuya Genda; Takafumi Ichida; Shotaro Sakisaka; Michio Sata; Eiji Tanaka; Ayano Inui; Hiroto Egawa; Kouji Umeshita; Hiroyuki Furukawa; Seiji Kawasaki; Yukihiro Inomata
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

Review 5.  Options for treatment of primary biliary cirrhosis.

Authors:  Ye H Oo; James Neuberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Transplantation in autoimmune liver diseases.

Authors:  Marcus Mottershead; James Neuberger
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

7.  Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Hepat Mon       Date:  2014-03-11       Impact factor: 0.660

Review 8.  Recurrence of cholestatic liver disease after living donor liver transplantation.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Junichi Kaneko; Junichi Togashi; Yuichi Matsui; Noriyo Yamashiki; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 9.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

10.  Development and internal validation of a predictive risk model for anxiety after completion of treatment for early stage breast cancer.

Authors:  Jenny Harris; Edward Purssell; Victoria Cornelius; Emma Ream; Anne Jones; Jo Armes
Journal:  J Patient Rep Outcomes       Date:  2020-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.